Chinese Standards Shop Partner of Google-Books Database: 169759 (Nov 10, 2019)
 HOME   Quotation   Tax   Examples Standard-List   Contact-Us   View-Cart
  

YY/T 1198-2013

Chinese Standard: 'YY/T 1198-2013'
Standard IDContents [version]USDSTEP2[PDF] delivered inStandard Title (Description)StatusRelated Standard
YY/T 1198-2013English170 Add to Cart 0--15 minutes. Auto immediate delivery. Aspartate aminotransferase diagnostic kit (IFCC method) Valid YY/T 1198-2013
YY/T 1198-2013Chinese14 Add to Cart <=1-day [PDF from Chinese Authority, or Standard Committee, or Publishing House]

 YY/T 1198-2013 -- Click to view a PDF In 0~10 minutes time, full copy of this English-PDF will be auto-immediately delivered to your email by our cloud-server.  
Detail Information of YY/T 1198-2013; YY/T1198-2013
Description (Translated English): Aspartate aminotransferase diagnostic kit(IFCC method)
Sector / Industry: Medical Device & Pharmaceutical Industry Standard (Recommended)
Classification of Chinese Standard: C44
Classification of International Standard: 11.100
Word Count Estimation: 10,131
Quoted Standard: YY/T 0466.1; GB/T 191
Drafting Organization: Chinese Institute of Food and Drug test
Administrative Organization: National medical clinical laboratory testing and in vitro diagnostic systems Standardization Technical Committee
Regulation (derived from): State Food and Drug Administration announcement 2013 No. 36; industry standard for filing Notice 2013 No. 12 (No. 168 overall)
Proposing organization: State Food and Drug Administration
Issuing agency(ies): State Food and Drug Administration
Summary: This standard specifies the aspartate aminotransferase measurement principle enzyme assay kit (IFCC method), requirements, test methods, marking, labeling and instructions for use, packaging, transport and storage of John. This standard applies to asparta

YY/T 1198-2013
YY
ICS 11.100
C 44
PHARMACEUTICAL INDUSTRY STANDARD
OF THE PEOPLE’S REPUBLIC OF CHINA
Aspartate aminotransferase diagnostic kit
(IFCC method)
天门冬氨酸氨基转移酶测定试剂盒 (IFCC法)
ISSUED ON. OCTOBER 21, 2013
IMPLEMENTED ON. OCTOBER 1, 2014
Issued by. State Food and Drug Administration
Table Contents
Foreword ... 3 
1 Scope ... 4 
2 Normative References ... 4 
3 Determination Principle ... 4 
4 Requirements ... 4 
5 Test Method ... 6 
6 Mark, Label and Instructions ... 9 
7 Packaging, Transport and Storage ... 10 
Foreword 
This Standard was drafted in accordance with the rules specified in GB/T 1.1-2009.
Please note that some contents in this Document may involve patents. The issuing organization
of this Document does not undertake the responsibility to identify these patents.
This Standard was proposed by State Food and Drug Administration.
This Standard shall be under the jurisdiction of the China Clinical Laboratory Testing and In
vitro Diagnostic Test System of Standardization Administration of China (SAC/TC 136).
Drafting organization of this Standard. National Institute for Food and Drug Control.
The main drafters of this Standard. Wang Yumei, Huang Jie, Liu Yan, and Gao Shangxian.
Aspartate aminotransferase diagnostic kit (lFCC method)
1 Scope 
This standard specifies the determination principle, requirements, test method, marks, signs,
instructions, packaging, transport and storage of aspartate aminotransferase diagnostic kit
(lFCC method).
This standard applies to the quality control of aspartate aminotransferase diagnostic kit (lFCC
method) This product is used for in-vitro quantitative determination of the aspartate
aminotransferase activity in human serum or plasma.
2 Normative References 
The following documents are indispensable for the application of this Document. For dated
references, only dated edition applies to this document. For undated references, the latest
edition (including all amendments) applies to this document.
YY/T 0466.1 Medical devices - Symbols to be used with medical device labels, labelling
and information to be supplied - Part 1. General requirements
GB/T 191 Packaging - Pictorial Marking for Handling of Goods
3 Determination Principle 
This method is the method recommended by IFCC. The reaction equation of method principle
is as follows.
L-aspartic acid + α-ketoglutaric acid → oxaloacetic acid + L-glutamic acid
Oxaloacetic acid + NADH + H+ → L-malic acid + NAD+
In the above coupled reaction, the oxidation rate of NADH is proportional to the enzymatic
activity of the specimen. NADH has characteristic absorption peak at the wavelength of 340 nm.
Therefore, the activity of ALT can be calculated through measuring the decline rate of NADH
absorbance.
The amino of L-aspartic acid will be transferred to malic dehydrogenase (MDH) under the
catalysis of AST. Then carry out coupled reaction; oxidize the NADH to NAD+. NADH has
characteristic absorption peak at the wavelength of 340 nm. Its oxidation rate is proportional to
the activity of AST in serum. Therefore, the activity of ALT (U/L) can be calculated through
measuring the decline rate of NADH absorbance at 340 nm.
4 Requirements 
4.1 Appearance
It shall meet the appearance requirements specified by the manufacturer.
AST
MDH
5.8 Stability
Take the reagent (kit), which is stored to the expiry of validity period under the specified storage
conditions OR under the accelerated test conditions specified by the manufacturer, for test. It
shall meet the requirements of 4.8.
6 Mark, Label and Instructions 
6.1 Mark and label of kit packaging box
The packaging-pictorial marking for handling of goods shall meet the requirements of GB/T 191,
and shall include at least the following contents.
a) Product name and specification;
b) Production batch number;
c) Expiry date;
d) Storage conditions.
6.2 Mark and label of single kit packaging bottle
The single kit packaging bottle shall include the following contents.
a) Product name and specification;
b) Trademark;
c) Net content of product;
d) Production batch number;
e) Expiry date;
f) Storage conditions.
6.3 Instructions
The instructions shall include the following contents.
a) Product name;
b) Packaging specification;
c) Intended use;
d) Test principle;
e) Main components;
f) Storage conditions and expiry date;
g) Applicable instruments;
h) Sample requirements;
i) Test method;
j) Reference value (reference interval);
k) Explanation of test results;
l) Limitation of the test method;
m) Product performance index;
n) Precautions;
o) References;
p) Manufacturing enterprise;
q) Production enterprise license number of medical device;
r) Registration certificate number of medical device;
s) Product standard number;
t) Approval and modification date of the instructions.
7 Packaging, T......
Related standard:   YY/T 1196-2013  YY/T 1197-2013
   
 
Privacy   ···   Product Quality   ···   About Us   ···   Refund Policy   ···   Fair Trading   ···   Quick Response
Field Test Asia Limited | Taxed in Singapore: 201302277C | Copyright 2012-2019